Xiong ZJ - Search Results

1

[Effects of AMPK on the transcriptional activity of FOXO1 and ubiquitin ligase MuRF1 expression in rat cardiomyocytes].

Chen BL, Xiong ZJ, Zhang CX, Ma YD, Meng RS, Chen GQ, Liu C, Dong YG. Chen BL, et al. Among authors: xiong zj. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Nov;30(11):2419-22. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 21097394 Chinese.

2

Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.

Chen BL, Ma YD, Meng RS, Xiong ZJ, Wang HN, Zeng JY, Liu C, Dong YG. Chen BL, et al. Among authors: xiong zj. Acta Pharmacol Sin. 2010 Jul;31(7):798-804. doi: 10.1038/aps.2010.73. Epub 2010 Jun 28. Acta Pharmacol Sin. 2010. PMID: 20581852 Free PMC article.

3

Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway.

Chen B, Wu Q, Xiong Z, Ma Y, Yu S, Chen D, Huang S, Dong Y. Chen B, et al. Acta Biochim Biophys Sin (Shanghai). 2016 Sep;48(9):827-32. doi: 10.1093/abbs/gmw076. Epub 2016 Aug 12. Acta Biochim Biophys Sin (Shanghai). 2016. PMID: 27521792 Free article.

4

Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.

Zhang CX, Pan SN, Meng RS, Peng CQ, Xiong ZJ, Chen BL, Chen GQ, Yao FJ, Chen YL, Ma YD, Dong YG. Zhang CX, et al. Among authors: xiong zj. Clin Exp Pharmacol Physiol. 2011 Jan;38(1):55-62. doi: 10.1111/j.1440-1681.2010.05461.x. Clin Exp Pharmacol Physiol. 2011. PMID: 21083698

5

MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals.

Chen B, Ma Y, Meng R, Xiong Z, Zhang C, Chen G, Zhang A, Dong Y. Chen B, et al. Acta Biochim Biophys Sin (Shanghai). 2010 Apr;42(4):253-8. doi: 10.1093/abbs/gmq012. Acta Biochim Biophys Sin (Shanghai). 2010. PMID: 20383463 Free article.

6

Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.

Xiong Z, Sun G, Zhu C, Cheng B, Zhang C, Ma Y, Dong Y. Xiong Z, et al. Eur J Pharmacol. 2010 Dec 15;649(1-3):277-84. doi: 10.1016/j.ejphar.2010.09.018. Epub 2010 Sep 19. Eur J Pharmacol. 2010. PMID: 20863781

7

Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression.

Ma Y, Chen Y, Yang Y, Chen B, Liu D, Xiong Z, Zhang C, Dong Y. Ma Y, et al. Biochem Pharmacol. 2013 Jan 15;85(2):223-33. doi: 10.1016/j.bcp.2012.10.025. Epub 2012 Nov 8. Biochem Pharmacol. 2013. PMID: 23142711

8

MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-κB/TGFβ1 pathway.

Ma Y, Chen B, Liu D, Yang Y, Xiong Z, Zeng J, Dong Y. Ma Y, et al. Biochem Pharmacol. 2011 May 15;81(10):1228-36. doi: 10.1016/j.bcp.2011.03.009. Epub 2011 Mar 21. Biochem Pharmacol. 2011. PMID: 21420391

9

p38 Mitogen-activated protein kinase regulates chamber-specific perinatal growth in heart.

Yokota T, Li J, Huang J, Xiong Z, Zhang Q, Chan T, Ding Y, Rau C, Sung K, Ren S, Kulkarni R, Hsiai T, Xiao X, Touma M, Minamisawa S, Wang Y. Yokota T, et al. J Clin Invest. 2020 Oct 1;130(10):5287-5301. doi: 10.1172/JCI135859. J Clin Invest. 2020. PMID: 32573492 Free PMC article.

10

lncRNA NBR2 attenuates angiotensin II-induced myocardial hypertrophy through repressing ER stress via activating LKB1/AMPK/Sirt1 pathway.

Zhu C, Wang M, Yu X, Shui X, Tang L, Chen Z, Xiong Z. Zhu C, et al. Bioengineered. 2022 May;13(5):13667-13679. doi: 10.1080/21655979.2022.2062527. Bioengineered. 2022. PMID: 35703318 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters